UnknownPhase 4

Beclomethasone in Healthy Athletes

30 participantsStarted 2022-09-01

Plain-language summary

The present study aims to assess her urine concentration of beclomethasone during and after one week of use according to the World Antidoping agency's regulations. The study will assess utility of dried blood spots to detect use of beclomethasone and the effect approved use of beclomethasone has on endurance performance in healthy (non-asthmatic ) athletes.

Who can participate

Age range18 Years – 35 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Healthy Maximal oxygen uptake \>60 in male and \>50 in female Signed informed consent. \- Exclusion Criteria: Intention to compete within 3 days after last dose of medicament Asthma diagnosis Use of anti-asthmatic medication last 12 months Upper chest infection last 4 weeks Contraindication to maximal exercise Contraindication to glucocorticoids Pregnancy or possible pregnancy Failure to obtain written informed consent

What they're measuring

20km cycling timetrial performance

Timeframe: 3 weeks

Trial details

NCT IDNCT05352191

SponsorWestern Norway University of Applied Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-01-01

Contact for this trial

Amund Riiser, PhD

92688239 amund.riiser@hvl.no

View on ClinicalTrials.gov More Performance, Detection trials